Related references
Note: Only part of the references are listed.Cisplatin Every 3 Weeks Versus Weekly With Definitive Concurrent Radiotherapy for Squamous Cell Carcinoma of the Head and Neck
Joshua M. Bauml et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2019)
Cisplatin Every 3 Weeks Versus Weekly With Definitive Concurrent Radiotherapy for Squamous Cell Carcinoma of the Head and Neck
Joshua M. Bauml et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2019)
Multicenter Trial of [18F]fluorodeoxyglucose Positron Emission Tomography/Computed Tomography Staging of Head and Neck Cancer and Negative Predictive Value and Surgical Impact in the N0 Neck: Results From ACRIN 6685
Val J. Lowe et al.
JOURNAL OF CLINICAL ONCOLOGY (2019)
Combining Immune Checkpoint Blockade and Tumor-Specific Vaccine for Patients With Incurable Human Papillomavirus 16-Related Cancer A Phase 2 Clinical Trial
Erminia Massarelli et al.
JAMA ONCOLOGY (2019)
Pembrolizumab versus methotrexate, docetaxel, or cetuximab for recurrent or metastatic head-and-neck squamous cell carcinoma (KEYNOTE-040): a randomised, open-label, phase 3 study
Ezra E. W. Cohen et al.
LANCET (2019)
Radiotherapy plus cisplatin or cetuximab in low-risk human papillomavirus-positive oropharyngeal cancer (De-ESCALaTE HPV): an open-label randomised controlled phase 3 trial
Hisham Mehanna et al.
LANCET (2019)
Radiotherapy plus cetuximab or cisplatin in human papillomavirus-positive oropharyngeal cancer (NRG Oncology RTOG 1016): a randomised, multicentre, non-inferiority trial
Maura L. Gillison et al.
LANCET (2019)
Safety and Efficacy of Durvalumab With or Without Tremelimumab in Patients With PD-L1-Low/Negative Recurrent or Metastatic HNSCC The Phase 2 CONDOR Randomized Clinical Trial
Lillian L. Siu et al.
JAMA ONCOLOGY (2019)
Variations in HPV function are associated with survival in squamous cell carcinoma
Frederico O. Gleber-Netto et al.
JCI INSIGHT (2019)
Validation of the eighth edition American Joint Committee on Cancer staging system for human papillomavirus-associated oropharyngeal cancer
John D. Cramer et al.
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK (2018)
Mature Results of a Prospective Study of Deintensified Chemoradiotherapy for Low-Risk Human Papillomavirus-Associated Oropharyngeal Squamous Cell Carcinoma
Bhishamjit S. Chera et al.
CANCER (2018)
Proton Therapy for Head and Neck Cancer
Joseph K. Kim et al.
CURRENT TREATMENT OPTIONS IN ONCOLOGY (2018)
Effect of Prophylactic Human Papillomavirus (HPV) Vaccination on Oral HPV Infections Among Young Adults in the United States
Anil K. Chaturvedi et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Induction Chemotherapy Followed by Cetuximab Radiotherapy Is Not Superior to Concurrent Chemoradiotherapy for Head and Neck Carcinomas: Results of the GORTEC 2007-02 Phase III Randomized Trial
Lionnel Geoffrois et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Once-a-Week Versus Once-Every-3-Weeks Cisplatin Chemoradiation for Locally Advanced Head and Neck Cancer: A Phase III Randomized Noninferiority Trial
Vanita Noronha et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Upfront surgery versus definitive chemoradiotherapy in patients with human Papillomavirus-associated oropharyngeal squamous cell cancer
Jacqueline R. Kelly et al.
ORAL ONCOLOGY (2018)
Nivolumab vs investigator's choice in recurrent or metastatic squamous cell carcinoma of the head and neck: 2-year long-term survival update of CheckMate 141 with analyses by tumor PD-L1 expression
Robert L. Ferris et al.
ORAL ONCOLOGY (2018)
Association of Human Papillomavirus Status at Head and Neck Carcinoma Subsites With Overall Survival
Hong Li et al.
JAMA OTOLARYNGOLOGY-HEAD & NECK SURGERY (2018)
Effect of Adding Motolimod to Standard Combination Chemotherapy and Cetuximab Treatment of Patients With Squamous Cell Carcinoma of the Head and Neck The Active8 Randomized Clinical Trial
Robert L. Ferris et al.
JAMA ONCOLOGY (2018)
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Freddie Bray et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
Human Papillomavirus Testing in Head and Neck Carcinomas: ASCO Clinical Practice Guideline Endorsement of the College of American Pathologists Guideline
Carole Fakhry et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
PATHOS: A phase II/III trial of risk-stratified, reduced intensity adjuvant treatment in patients undergoing transoral surgery for human papillomavirus (HPV)-positive oropharyngeal cancer.
Mererid Evans et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
A phase II randomized trial of nivolumab with stereotactic body radiotherapy (SBRT) versus nivolumab alone in metastatic (M1) head and neck squamous cell carcinoma (HNSCC).
Sean Matthew McBride et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Results of a randomized phase III study of nimotuzumab in combination with concurrent radiotherapy and cisplatin versus radiotherapy and cisplatin alone, in locally advanced squamous cell carcinoma of the head and neck.
Vijay Maruti Patil et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Phase II study: Induction chemotherapy and transoral surgery as definitive treatment (Tx) for locally advanced oropharyngeal squamous cell carcinoma (OPSCC): A novel approach.
Robert S. Siegel et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Overall Survival with Durvalumab after Chemoradiotherapy in Stage III NSCLC
S. J. Antonia et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Patient-Reported Quality-of-Life Outcomes After De-Escalated Chemoradiation for Human Papillomavirus-Positive Oropharyngeal Carcinoma: Findings From a Phase 2 Trial
John V. Hegde et al.
CANCER (2018)
Continuing rise in oropharyngeal cancer in a high HPV prevalence area: A Danish population-based study from 2011 to 2014
Amanda-Louise Fenger Carlander et al.
EUROPEAN JOURNAL OF CANCER (2017)
Two-Year Results for MC1273, a Phase 2 Evaluation of Aggressive Dose De-Escalation for Adjuvant Chemoradiation in HPV plus Oropharynx Squamous Cell Carcinoma (OPSCC)
D. J. Ma et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2017)
Development and Validation of Nomograms Predictive of Overall and Progression-Free Survival in Patients With Oropharyngeal Cancer
Carole Fakhry et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
Radiation Therapy for Oropharyngeal Squamous Cell Carcinoma: American Society of Clinical Oncology Endorsement of the American Society for Radiation Oncology Evidence-Based Clinical Practice Guideline
Harry Quon et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
E1308: Phase II Trial of Induction Chemotherapy Followed by Reduced-Dose Radiation and Weekly Cetuximab in Patients With HPV-Associated Resectable Squamous Cell Carcinoma of the Oropharynx-ECOG-ACRIN Cancer Research Group
Shanthi Marur et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
Pembrolizumab for Platinum- and Cetuximab-Refractory Head and Neck Cancer: Results From a Single-Arm, Phase II Study
Joshua Bauml et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
Reduced-dose radiotherapy for human papillomavirus-associated squamous-cell carcinoma of the oropharynx: a single-arm, phase 2 study
Allen M. Chen et al.
LANCET ONCOLOGY (2017)
Nivolumab versus standard, single-agent therapy of investigator's choice in recurrent or metastatic squamous cell carcinoma of the head and neck (CheckMate 141): health-related quality-of-life results from a randomised, phase 3 trial
Kevin J. Harrington et al.
LANCET ONCOLOGY (2017)
Role of radiotherapy fractionation in head and neck cancers (MARCH): an updated meta-analysis
Benjamin Lacas et al.
LANCET ONCOLOGY (2017)
Buparlisib and paclitaxel in patients with platinum-pretreated recurrent or metastatic squamous cell carcinoma of the head and neck (BERIL-1): a randomised, double-blind, placebo-controlled phase 2 trial
Denis Soulieres et al.
LANCET ONCOLOGY (2017)
Elements of cancer immunity and the cancer-immune set point
Daniel S. Chen et al.
NATURE (2017)
Weekly Low-Dose Versus Three-Weekly High-Dose Cisplatin for Concurrent Chemoradiation in Locoregionally Advanced Non-Nasopharyngeal Head and Neck Cancer: A Systematic Review and Meta-Analysis of Aggregate Data
Petr Szturz et al.
ONCOLOGIST (2017)
Transoral robotic surgery for management of cervical unknown primary squamous cell carcinoma: Updates on efficacy, surgical technique and margin status
Mathew Geltzeiler et al.
ORAL ONCOLOGY (2017)
Transoral Robotic Surgery-Assisted Endoscopy With Primary Site Detection and Treatment in Occult Mucosal Primaries
Kyle M. Hatten et al.
JAMA OTOLARYNGOLOGY-HEAD & NECK SURGERY (2017)
The negative predictive value (NPV) of FDG-PET/CT in the Head and Neck Squamous Cell Carcinoma (HNSCC) NO patient, the first report of the ACRIN 6685 trial.
Brendan C. Stack et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
Cancer Statistics, 2017
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2017)
A Prospective Evaluation of Short-Term Dysphagia After Transoral Robotic Surgery for Squamous Cell Carcinoma of the Oropharynx
William G. Albergotti et al.
CANCER (2017)
TRAF3/CYLD mutations identify a distinct subset of human papillomavirus-associated head and neck squamous cell carcinoma
Michael Hajek et al.
CANCER (2017)
Identification of the Cell-Intrinsic and -Extrinsic Pathways Downstream of EGFR and IFNγ That Induce PD-L1 Expression in Head and Neck Cancer
Fernando Concha-Benavente et al.
CANCER RESEARCH (2016)
Antitumor Activity of Pembrolizumab in Biomarker-Unselected Patients With Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma: Results From the Phase Ib KEYNOTE-012 Expansion Cohort
Laura Q. M. Chow et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
Development and validation of a staging system for HPV-related oropharyngeal cancer by the International Collaboration on Oropharyngeal cancer Network for Staging (ICON-S): a multicentre cohort study
Brian O'Sullivan et al.
LANCET ONCOLOGY (2016)
Safety and clinical activity of pembrolizumab for treatment of recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-012): an open-label, multicentre, phase 1b trial
Tanguy Y. Seiwert et al.
LANCET ONCOLOGY (2016)
PET-CT Surveillance versus Neck Dissection in Advanced Head and Neck Cancer
Hisham Mehanna et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Nivolumab for Recurrent Squamous-Cell Carcinoma of the Head and Neck
R. L. Ferris et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Phase I trial of palbociclib, a selective cyclin dependent kinase 4/6 inhibitor, in combination with cetuximab in patients with recurrent/metastatic head and neck squamous cell carcinoma
Loren Michel et al.
ORAL ONCOLOGY (2016)
Intensity-modulated proton beam therapy (IMPT) versus intensity-modulated photon therapy (IMRT) for patients with oropharynx cancer - A case matched analysis
Pierre Blanchard et al.
RADIOTHERAPY AND ONCOLOGY (2016)
Prognostic and predictive value of EGFR in head and neck squamous cell carcinoma
Paolo Bossi et al.
ONCOTARGET (2016)
Survival and Gastrostomy Prevalence in Patients With Oropharyngeal Cancer Treated With Transoral Robotic Surgery vs Chemoradiotherapy
Arun Sharma et al.
JAMA OTOLARYNGOLOGY-HEAD & NECK SURGERY (2016)
A Contemporary Analysis of Surgical Trends in the Treatment of Squamous Cell Carcinoma of the Oropharynx from 1998 to 2012: A Report from the National Cancer Database
Erik Liederbach et al.
ANNALS OF SURGICAL ONCOLOGY (2015)
Sentinel European Node Trial (SENT): 3-year results of sentinel node biopsy in oral cancer
Clare Schilling et al.
EUROPEAN JOURNAL OF CANCER (2015)
Prognoses and improvement for head and neck cancers diagnosed in Europe in early 2000s: The EUROCARE-5 population-based study
Gemma Gatta et al.
EUROPEAN JOURNAL OF CANCER (2015)
Epidemiology of Human Papillomavirus-Positive Head and Neck Squamous Cell Carcinoma
Maura L. Gillison et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Management of Squamous Cancer Metastatic to Cervical Nodes With an Unknown Primary Site
Thomas J. Galloway et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Transoral Endoscopic Head and Neck Surgery and Its Role Within the Multidisciplinary Treatment Paradigm of Oropharynx Cancer: Robotics, Lasers, and Clinical Trials
F. Christopher Holsinger et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Refining American Joint Committee on Cancer/Union for International Cancer Control TNM Stage and Prognostic Groups for Human Papillomavirus-Related Oropharyngeal Carcinomas
Shao Hui Huang et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Oral Cavity Carcinoma: Current Management, Controversies, and Future Directions
Steven B. Chinn et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Immunology and Immunotherapy of Head and Neck Cancer
Robert L. Ferris
JOURNAL OF CLINICAL ONCOLOGY (2015)
Advances in Radiotherapy for Head and Neck Cancer
Vincent Gregoire et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Afatinib versus methotrexate as second-line treatment in patients with recurrent or metastatic squamous-cell carcinoma of the head and neck progressing on or after platinum-based therapy (LUX-Head & Neck 1): an open-label, randomised phase 3 trial
Jean-Pascal H. Machiels et al.
LANCET ONCOLOGY (2015)
Comprehensive genomic characterization of head and neck squamous cell carcinomas
Michael S. Lawrence et al.
NATURE (2015)
Elective versus Therapeutic Neck Dissection in Node-Negative Oral Cancer
Anil K. D'Cruz et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Mutational landscape determines sensitivity to PD-1 blockade in non-small cell lung cancer
Naiyer A. Rizvi et al.
SCIENCE (2015)
Phospho-T356RB1 predicts survival in HPV-negative squamous cell carcinoma of the head and neck
Tim N. Beck et al.
ONCOTARGET (2015)
Oncologic Outcomes After Transoral Robotic Surgery A Multi-institutional Study
John R. de Almeida et al.
JAMA OTOLARYNGOLOGY-HEAD & NECK SURGERY (2015)
A Multi-Institution Pooled Analysis of Gastrostomy Tube Dependence in Patients With Oropharyngeal Cancer Treated With Definitive Intensity-Modulated Radiotherapy
Jeremy Setton et al.
CANCER (2015)
Integrative Analysis of Head and Neck Cancer Identifies Two Biologically Distinct HPV and Three Non-HPV Subtypes
Michaela K. Keck et al.
CLINICAL CANCER RESEARCH (2015)
Management of human papillomavirus-related unknown primaries of the head and neck with a transoral surgical approach
Evan M. Graboyes et al.
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK (2015)
Safety and efficacy of MEDI4736, an anti-PD-L1 antibody, in patients from a squamous cell carcinoma of the head and neck (SCCHN) expansion cohort.
Neil Howard Segal et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Phase I Dendritic Cell p53 Peptide Vaccine for Head and Neck Cancer
Patrick J. Schuler et al.
CLINICAL CANCER RESEARCH (2014)
Transoral robotic approach to carcinoma of unknown primary
Kasim Durmus et al.
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK (2014)
Randomized Phase II/III Trial of Post-operative Chemoradiotherapy Comparing 3-Weekly Cisplatin with Weekly Cisplatin in High-risk Patients with Squamous Cell Carcinoma of Head and Neck: Japan Clinical Oncology Group Study (JCOG1008)
Futoshi Kunieda et al.
JAPANESE JOURNAL OF CLINICAL ONCOLOGY (2014)
Randomized Phase III Trial to Test Accelerated Versus Standard Fractionation in Combination With Concurrent Cisplatin for Head and Neck Carcinomas in the Radiation Therapy Oncology Group 0129 Trial: Long-Term Report of Efficacy and Toxicity
Phuc Felix Nguyen-Tan et al.
JOURNAL OF CLINICAL ONCOLOGY (2014)
Phase III Randomized Trial of Induction Chemotherapy in Patients With N2 or N3 Locally Advanced Head and Neck Cancer
Ezra E. W. Cohen et al.
JOURNAL OF CLINICAL ONCOLOGY (2014)
Postoperative Chemoradiotherapy and Cetuximab for High-Risk Squamous Cell Carcinoma of the Head and Neck: Radiation Therapy Oncology Group RTOG-0234
Paul M. Harari et al.
JOURNAL OF CLINICAL ONCOLOGY (2014)
p16 Protein Expression and Human Papillomavirus Status As Prognostic Biomarkers of Nonoropharyngeal Head and Neck Squamous Cell Carcinoma
Christine H. Chung et al.
JOURNAL OF CLINICAL ONCOLOGY (2014)
Dose to the inferior pharyngeal constrictor predicts prolonged gastrostomy tube dependence with concurrent intensity-modulated radiation therapy and chemotherapy for locally-advanced head and neck cancer
Gregory Vlacich et al.
RADIOTHERAPY AND ONCOLOGY (2014)
Cigarette, Cigar, and Pipe Smoking and the Risk of Head and Neck Cancers: Pooled Analysis in the International Head and Neck Cancer Epidemiology Consortium
Annah Wyss et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2013)
Early-stage squamous cell carcinoma of the oropharynx: Radiotherapy vs. Trans-Oral Robotic Surgery (ORATOR) - study protocol for a randomized phase II trial
Anthony C. Nichols et al.
BMC CANCER (2013)
PD-1-Expressing Tumor-Infiltrating T Cells Are a Favorable Prognostic Biomarker in HPV-Associated Head and Neck Cancer
Cecile Badoual et al.
CANCER RESEARCH (2013)
Diagnostic value of sentinel lymph node biopsy in head and neck cancer: a meta-analysis
C. F. Thompson et al.
EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY (2013)
Prevalence of human papillomavirus in oropharyngeal and nonoropharyngeal head and neck cancersystematic review and meta-analysis of trends by time and region
Hisham Mehanna et al.
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK (2013)
Taxane-Cisplatin-Fluorouracil As Induction Chemotherapy in Locally Advanced Head and Neck Cancers: An Individual Patient Data Meta-Analysis of the Meta-Analysis of Chemotherapy in Head and Neck Cancer Group
Pierre Blanchard et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Deintensification Candidate Subgroups in Human Papillomavirus-Related Oropharyngeal Cancer According to Minimal Risk of Distant Metastasis
Brian O'Sullivan et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Induction chemotherapy followed by concurrent chemoradiotherapy (sequential chemoradiotherapy) versus concurrent chemoradiotherapy alone in locally advanced head and neck cancer (PARADIGM): a randomised phase 3 trial
Robert Haddad et al.
LANCET ONCOLOGY (2013)
Cisplatin and fluorouracil with or without panitumumab in patients with recurrent or metastatic squamous-cell carcinoma of the head and neck (SPECTRUM): an open-label phase 3 randomised trial
Jan B. Vermorken et al.
LANCET ONCOLOGY (2013)
Signatures of mutational processes in human cancer
Ludmil B. Alexandrov et al.
NATURE (2013)
Nivolumab plus Ipilimumab in Advanced Melanoma
Jedd D. Wolchok et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Reduced Prevalence of Oral Human Papillomavirus (HPV) 4 Years after Bivalent HPV Vaccination in a Randomized Clinical Trial in Costa Rica
Rolando Herrero et al.
PLOS ONE (2013)
Robotic Surgery for Primary Head and Neck Squamous Cell Carcinoma of Unknown Site
Sapna A. Patel et al.
JAMA OTOLARYNGOLOGY-HEAD & NECK SURGERY (2013)
Adaptive Radiotherapy for Head-and-Neck Cancer: Initial Clinical Outcomes From a Prospective Trial
David L. Schwartz et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2012)
Tobacco Smoking and Increased Risk of Death and Progression for Patients With p16-Positive and p16-Negative Oropharyngeal Cancer
Maura L. Gillison et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Transoral robotic surgery: A multicenter study to assess feasibility, safety, and surgical margins
Gregory S. Weinstein et al.
LARYNGOSCOPE (2012)
The comparison between weekly and three-weekly cisplatin delivered concurrently with radiotherapy for patients with postoperative high-risk squamous cell carcinoma of the oral cavity
Din-Li Tsan et al.
RADIATION ONCOLOGY (2012)
A prospective, randomized study comparing outcomes and toxicities of intensity-modulated radiotherapy vs. conventional two-dimensional radiotherapy for the treatment of nasopharyngeal carcinoma
Gang Peng et al.
RADIOTHERAPY AND ONCOLOGY (2012)
Associations between Oral HPV16 Infection and Cytopathology: Evaluation of an Oropharyngeal Pap-Test Equivalent in High-Risk Populations
Carole Fakhry et al.
CANCER PREVENTION RESEARCH (2011)
COMPARISON OF MORBIDITY BETWEEN SENTINEL NODE BIOPSY AND ELECTIVE NECK DISSECTION FOR TREATMENT OF THE NO NECK IN PATIENTS WITH ORAL SQUAMOUS CELL CARCINOMA
Karin Murer et al.
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK (2011)
TRANSORAL LASER MICROSURGERY AS PRIMARY TREATMENT FOR ADVANCED-STAGE OROPHARYNGEAL CANCER: A UNITED STATES MULTICENTER STUDY
Bruce H. Haughey et al.
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK (2011)
Low human papillomavirus prevalence in head and neck cancer: results from two large case-control studies in high-incidence regions
Karina Braga Ribeiro et al.
INTERNATIONAL JOURNAL OF EPIDEMIOLOGY (2011)
PHASE III STUDY OF RADIATION THERAPY WITH OR WITHOUT CIS-PLATINUM IN PATIENTS WITH UNRESECTABLE SQUAMOUS OR UNDIFFERENTIATED CARCINOMA OF THE HEAD AND NECK: AN INTERGROUP TRIAL OF THE EASTERN COOPERATIVE ONCOLOGY GROUP (E2382)
Harry Quon et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2011)
Human Papillomavirus and Rising Oropharyngeal Cancer Incidence in the United States
Anil K. Chaturvedi et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Zalutumumab plus best supportive care versus best supportive care alone in patients with recurrent or metastatic squamous-cell carcinoma of the head and neck after failure of platinum-based chemotherapy: an open-label, randomised phase 3 trial
Jean-Pascal Machiels et al.
LANCET ONCOLOGY (2011)
Parotid-sparing intensity modulated versus conventional radiotherapy in head and neck cancer (PARSPORT): a phase 3 multicentre randomised controlled trial
Christopher M. Nutting et al.
LANCET ONCOLOGY (2011)
Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): A comprehensive analysis by tumour site
Pierre Blanchard et al.
RADIOTHERAPY AND ONCOLOGY (2011)
Exome Sequencing of Head and Neck Squamous Cell Carcinoma Reveals Inactivating Mutations in NOTCH1
Nishant Agrawal et al.
SCIENCE (2011)
The Mutational Landscape of Head and Neck Squamous Cell Carcinoma
Nicolas Stransky et al.
SCIENCE (2011)
Sentinel Node Biopsy in Head and Neck Squamous Cell Cancer: 5-Year Follow-Up of a European Multicenter Trial
Lee W. T. Alkureishi et al.
ANNALS OF SURGICAL ONCOLOGY (2010)
Phase I/II Study of Oncolytic HSVGM-CSF in Combination with Radiotherapy and Cisplatin in Untreated Stage III/IV Squamous Cell Cancer of the Head and Neck
Kevin J. Harrington et al.
CLINICAL CANCER RESEARCH (2010)
Tobacco Use in Human Papillomavirus-Positive Advanced Oropharynx Cancer Patients Related to Increased Risk of Distant Metastases and Tumor Recurrence
Jessica H. Maxwell et al.
CLINICAL CANCER RESEARCH (2010)
ELECTIVE RADIOTHERAPY OR NECK DISSECTION FOR CT-STAGED T1-2N0 ORAL TONGUE CANCER Reply
Sinead Brennan
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK (2010)
Tumor Antigen-Targeted, Monoclonal Antibody-Based Immunotherapy: Clinical Response, Cellular Immunity, and Immunoescape
Robert L. Ferris et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Sentinel Lymph Node Biopsy Accurately Stages the Regional Lymph Nodes for T1-T2 Oral Squamous Cell Carcinomas: Results of a Prospective Multi-Institutional Trial
Francisco J. Civantos et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Intensity-Modulated Chemoradiotherapy Aiming to Reduce Dysphagia in Patients With Oropharyngeal Cancer: Clinical and Functional Results
Felix Y. Feng et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Selective Neck Dissection and Deintensified Postoperative Radiation and Chemotherapy for Oropharyngeal Cancer: A Subset Analysis of the University of Pennsylvania Transoral Robotic Surgery Trial
Gregory S. Weinstein et al.
LARYNGOSCOPE (2010)
Human Papillomavirus and Survival of Patients with Oropharyngeal Cancer
K. Kian Ang et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Assessment by a deformable registration method of the volumetric and positional changes of target volumes and organs at risk in pharyngo-laryngeal tumors treated with concomitant chemo-radiation
Pierre Castadot et al.
RADIOTHERAPY AND ONCOLOGY (2010)
The comparison of weekly and three-weekly cisplatin chemotherapy concurrent with radiotherapy in patients with previously untreated inoperable non-metastatic squamous cell carcinoma of the head and neck
Kazim Uygun et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2009)
Current trends in initial management of oropharyngeal cancer: the declining use of open surgery
Missak Haigentz et al.
EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY (2009)
FUNCTION, POSTOPERATIVE MORBIDITY, AND QUALITY OF LIFE AFTER CERVICAL SENTINEL NODE BIOPSY AND AFTER SELECTIVE NECK DISSECTION
Franziska Schiefke et al.
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK (2009)
IMPACT OF RECONSTRUCTIVE MICROSURGERY IN PATIENTS WITH ADVANCED ORAL CAVITY CANCERS
Matthew M. Hanasono et al.
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK (2009)
Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): An update on 93 randomised trials and 17,346 patients
Jean-Pierre Pignon et al.
RADIOTHERAPY AND ONCOLOGY (2009)
Head and neck cancer - An evolving treatment paradigm
David M. Cognetti et al.
CANCER (2008)
Factors associated with severe late toxicity after concurrent chemoradiation for locally advanced head and neck cancer: An RTOG analysis
Mitchell Machtay et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Platinum-based chemotherapy plus cetuximab in head and neck cancer
Jan B. Vermorken et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Prospective Randomized study of intensity-modulated radiotherapy on salivary gland function in early-stage nasopharyngeal carcinoma patients
Michael K. M. Kam et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Cisplatin and fluorouracil alone or with docetaxel in head and neck cancer
Marshall R. Posner et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Cisplatin, fluorouracil, and docetaxel in unresectable head and neck cancer
Jan B. Vermorken et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Trends in head and neck cancer incidence in relation to smoking prevalence - An emerging epidemic of human papillomavirus-associated cancers?
Erich M. Sturgis et al.
CANCER (2007)
Phase II study of combination cetuximab and weekly paclitaxel in patients with metastatic/recurrent squamous cell carcinoma of head and neck (SCCHN): Spanish Head and Neck Cancer Group (TTCC)
R. Hitt et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Case-control study of human papillomavirus and oropharyngeal cancer
Gypsyamber D'Souza et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
HPV integration begins in the tonsillar crypt and leads to the alteration of p16, EGFR and c-myc during tumor formation
Se-Heon Kim et al.
INTERNATIONAL JOURNAL OF CANCER (2007)
Therapeutic outcomes of laryngeal cancer at Kyoto University Hospital for 10 years
Yoshihiro Tamura et al.
ACTA OTO-LARYNGOLOGICA (2007)
Open-label, uncontrolled, multicenter phase II study to evaluate the efficacy and toxicity of cetuximab as a single agent in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck who failed to respond to platinum-based therapy
Jan B. Vermorken et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Xerostomia and quality of life after intensity-modulated radiotherapy vs. conventional radiotherapy for early-stage nasopharyngeal carcinoma: Initial report on a randomized controlled clinical trial
Edmond H. N. Pow et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2006)
Transoral robotic surgery (TORS) for base of tongue neoplasms
Bert W. O'Malley et al.
LARYNGOSCOPE (2006)
Epidermal growth factor receptor biology in head and neck cancer
Shailaja Kalyankrishna et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Sustained efficacy up to 4-5 years of a bivalent L1 virus-like particle vaccine against human papillomavirus types 16 and 18: follow-up from a randomised control trial
DM Harper et al.
LANCET (2006)
Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck
JA Bonner et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Phase III randomized trial of cisplatin plus placebo compared with cisplatin plus cetuximab in metastatic/recurrent head and neck cancer: An eastern cooperative oncology group study
B Burtness et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Molecular classification of head and neck squamous cell carcinomas using patterns of gene expression
CH Chung et al.
CANCER CELL (2004)
Tumor-associated B7-H1 promotes T-cell apoptosis: A potential mechanism of immune evasion
HD Dong et al.
NATURE MEDICINE (2002)
Evidence for a causal association between human papillomavirus and a subset of head and neck cancers
ML Gillison et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2000)
Cervical lymph node metastases from unknown primary tumours - Results from a national survey by the Danish Society for Head and Neck Oncology
C Grau et al.
RADIOTHERAPY AND ONCOLOGY (2000)
Share Paper
